Enliven Therapeutics (ELVN) Accumulated Depreciation (2019 - 2026)
Enliven Therapeutics (ELVN) posted Accumulated Depreciation of $250,000 for Q2 2026, down 76.7% from $1.07 million a year earlier but up 2.9% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Accumulated Depreciation (2019 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics' Accumulated Depreciation came in at $229,000, down 75.1% from FY2024.
- Annual Accumulated Depreciation shows a five-year compound annual growth rate of 12.0% (FY2020 to FY2025).
- In prior years, Enliven Therapeutics' Accumulated Depreciation was $919,000 in FY2024 (+37.0%), $671,000 in FY2023 (+79.4%), $374,000 in FY2022 (+63.3%) and $229,000 in FY2021 (+76.2%).
- Quarterly Accumulated Depreciation has run from a low of $229,000 in Q4 2021 to a high of $1.14 million in Q3 2025 over five years.
- On a year-over-year basis, Accumulated Depreciation has declined in each of the last three quarters, with an average decline of 6.3% over the last eight quarters.
- The strongest year-over-year quarter for Accumulated Depreciation in the past five years was Q4 2023, with growth of 79.4%; the weakest was Q2 2026, with a decline of 76.7%.
- According to Business Quant data, Accumulated Depreciation for the three prior quarters was $243,000 (Q1 2026), $229,000 (Q4 2025) and $1.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Enliven Therapeutics | 3.36 Bn | 3.36 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 250,000.00 |
| Mar 31, 2026 | 243,000.00 |
| Dec 31, 2025 | 229,000.00 |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 993,000.00 |
| Dec 31, 2024 | 919,000.00 |
| Sep 30, 2024 | 908,000.00 |
| Jun 30, 2024 | 828,000.00 |
| Mar 31, 2024 | 750,000.00 |
| Dec 31, 2023 | 671,000.00 |
| Sep 30, 2023 | 593,000.00 |
| Jun 30, 2023 | 515,000.00 |
| Mar 31, 2023 | 441,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Dec 31, 2021 | 229,000.00 |
| Dec 31, 2020 | 130,000.00 |
| Dec 31, 2019 | 33,000.00 |
API Access
Enliven Therapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();